FDA move allowing more e-cigarettes and nicotine pouches into U.S. blindsides officials
Summary
The U.S. Food and Drug Administration (FDA) recently made a sudden decision to allow more e-cigarettes and nicotine pouches onto the market without full review. Some FDA staff were surprised by the change and were not consulted before the guidelines were published. The move comes after President Donald Trump approved firing the FDA commissioner, Marty Makary, who resigned shortly after.Key Facts
- The FDA issued new guidelines allowing certain nicotine products to be sold before full safety and health reviews.
- FDA tobacco center staff responsible for regulating vaping were not consulted and learned about the change only hours before it became public.
- The policy change happened just days before FDA Commissioner Marty Makary resigned.
- The guidelines skipped the normal public comment period required by law.
- President Trump approved a plan to remove Makary, with his resignation shortly following.
- The new FDA statement claims the approach helps protect youth from nicotine addiction while supporting adults who want to quit smoking.
- Underage vaping in the U.S. has dropped to the lowest level in over a decade due to recent restrictions and the pandemic.
- Major tobacco companies, which have donated to political groups supporting Trump, are heavily invested in e-cigarettes and nicotine pouches.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.